My watch list
my.bionity.com  
Login  

Diamyd Medical is a life science company developing treatments for diabetes and its complications. The company’s furthest developed project is the GAD-based drug Diamyd® for autoimmune diabetes for which Phase III studies are planned. Diamyd® has demonstrated significant and positive results in Phase II clinical trials in Sweden.

More about Diamyd Medical
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE